JuvRX Green Cells Background

JuvRx

Therapies that target aging and age-related disease.

Our focus is on traditional prescription medicines to modify aging and prevent diseases.

JuvRx Petri Dish

About RX

We see profound scientific advances in the area of healthy aging and longevity. Our goal is to help individuals reimagine their short and long-term health. We’re also positioned to impact the greater healthcare system, as it reinvents how to serve patients, confronting the diseases related to aging. With a team of world class drug developers, we’re targeting the fundamental molecular, cellular and tissue pathways of aging. We identify pharmacotherapies of great potential and manage their development to maximize the chance and speed of regulatory approval.

In the News

Juvenescence

Juvenescence Appoints CEO for Souvien & Epigenetic Division

Juvenescence Limited, a life sciences company focused on modifying aging and increasing human healthspan, is pleased to announce the appointment of Dr. Ellen Donnelly to its Senior Leadership Team.

June 10, 2020

Read More
Juvenescence

Extension of NetraMark’s NetraPharma Collaboration with Juvenescence

NetraMark Corp. and Juvenescence are excited to announce the extension of their collaboration agreement to include drug repurposing and drug discovery.

December 9, 2019

Read More
Juvenescence

Juvenescence Capitalizes BYOMass

Juvenescence is pleased to announce its latest equity investment in BYOMass, a Massachusetts-based company focused on central control of metabolism in the context of aging and age-related diseases.

March 26, 2019

Read More

Contact Us

We are here to help answer any questions you might have.